Form 4 for CL Colgate-Palmolive
Accepted 2024-05-03 00:00:00 ET · period of report 2024-05-01 · accession 0001225208-24-005538 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-03 | 2024-05-01 | CL | Massey Sally | CHRO | S - Sale+OE | $91.92 | -6,115 | 13.9K | -31% | -$562.1K |
| D | 2024-05-03 | 2024-05-01 | CL | Massey Sally | CHRO | M - OptEx | $72.29 | +6,115 | 20.0K | +44% | +$442.1K |
| D | 2024-05-03 | 2024-05-01 | CL | Massey Sally | CHRO | M - OptEx | $0.00 | -6,115 | 12.2K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-01 | S | D | 6,115 | $91.92 | 13,924 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-01 | M | A | 6,115 | $72.29 | 20,039 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-05-01 | M | D | 6,115 | $0.00 | 12,226 | D | $72.29 · — to 2027-09-12 | 6,115 Common Stock | (F3) Option became exercisable in one-third increments beginning on the first anniversary of the September 12, 2019 grant date. |